Can Limited Scientific Value of Potential Pandemic Pathogen Experiments Justify the Risks?

QR Code

Can Limited Scientific Value of Potential Pandemic Pathogen Experiments Justify the Risks?

Saved in:

Bibliographic Details
Main Author:	Marc Lipsitch
Format:	article
Language:	EN
Published:	American Society for Microbiology 2014
Subjects:	Microbiology QR1-502
Online Access:	https://doaj.org/article/f2bacd0cb23f4fb6a1f7197e5ad19b42
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reply to “Can Limited Scientific Value of Potential Pandemic Pathogen Experiments Justify the Risks?”
by: Arturo Casadevall, et al.
Published: (2014)

Rethinking Biosafety in Research on Potential Pandemic Pathogens
by: Marc Lipsitch, et al.
Published: (2012)

Moratorium on Research Intended To Create Novel Potential Pandemic Pathogens
by: Marc Lipsitch, et al.
Published: (2014)

Erratum for Lipsitch and Inglesby, Moratorium on Research Intended To Create Novel Potential Pandemic Pathogens
by: Marc Lipsitch, et al.
Published: (2015)

An Epistemological Perspective on the Value of Gain-of-Function Experiments Involving Pathogens with Pandemic Potential
by: Arturo Casadevall, et al.
Published: (2014)

Assessing and Managing the Risks of Potential Pandemic Pathogen Research
by: Daniel J. Rozell
Published: (2015)

Proposed Changes to U.S. Policy on Potential Pandemic Pathogen Oversight and Implementation
by: Thomas V. Inglesby, et al.
Published: (2020)

Risks and Benefits of Gain-of-Function Experiments with Pathogens of Pandemic Potential, Such as Influenza Virus: a Call for a Science-Based Discussion
by: Arturo Casadevall, et al.
Published: (2014)

Danger of Potential-Pandemic-Pathogen Research Enterprises
by: Lynn C. Klotz
Published: (2015)

Vagueness and Costs of the Pause on Gain-of-Function (GOF) Experiments on Pathogens with Pandemic Potential, Including Influenza Virus
by: Michael J. Imperiale, et al.
Published: (2014)

How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?
by: Marc Lipsitch, et al.
Published: (2016)

Is the Debate and “Pause” on Experiments That Alter Pathogens with Pandemic Potential Influencing Future Plans of Graduate Students and Postdoctoral Fellows?
by: Julie K. Pfeiffer
Published: (2015)

<italic toggle="yes">mBio</italic> Addresses the Pause in Gain-of-Function (GOF) Experiments Involving Pathogens with Pandemic Potential (PPP)
by: Arturo Casadevall, et al.
Published: (2014)

Reply to “Studies on Influenza Virus Transmission between Ferrets: the Public Health Risks Revisited”
by: Marc Lipsitch, et al.
Published: (2015)

Does Pandemic A/H1N1 Virus Have the Potential To Become More Pathogenic?
by: Natalia A. Ilyushina, et al.
Published: (2010)

Ethical alternatives to experiments with novel potential pandemic pathogens.
by: Marc Lipsitch, et al.
Published: (2014)

Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments
by: Nicholas Greig Evans
Published: (2014)

Reply to “Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments”
by: Arturo Casadevall, et al.
Published: (2014)

The Pathogenic Potential of a Microbe
by: Arturo Casadevall
Published: (2017)

Influenza Gain-of-Function Experiments: Their Role in Vaccine Virus Recommendation and Pandemic Preparedness
by: S. Schultz-Cherry, et al.
Published: (2014)

A Single Human Cerebral Malaria Histopathologic Study Can Be Worth a Thousand Experiments
by: David J. Sullivan
Published: (2015)

Rapid Proliferation of Pandemic Research: Implications for Dual-Use Risks
by: Sriharshita Musunuri, et al.
Published: (2021)

Field Science—the Nature and Utility of Scientific Fields
by: Arturo Casadevall, et al.
Published: (2015)

Use of Highly Pathogenic Avian Influenza A(H5N1) Gain-Of-Function Studies for Molecular-Based Surveillance and Pandemic Preparedness
by: C. Todd Davis, et al.
Published: (2014)

H7N9 Avian Influenza A Virus and the Perpetual Challenge of Potential Human Pandemicity
by: David M. Morens, et al.
Published: (2013)

Rethinking Gain-of-Function Experiments in the Context of the COVID-19 Pandemic
by: Michael J. Imperiale, et al.
Published: (2020)

Oral Epithelial Cells Distinguish between <i>Candida</i> Species with High or Low Pathogenic Potential through MicroRNA Regulation
by: Márton Horváth, et al.
Published: (2021)

Comparative Genomics of Recent Shiga Toxin-Producing <named-content content-type="genus-species">Escherichia coli</named-content> O104:H4: Short-Term Evolution of an Emerging Pathogen
by: Yonatan H. Grad, et al.
Published: (2013)

Pandemics and People
by: Michael J. Imperiale
Published: (2020)

Males Are Overrepresented among Life Science Researchers Committing Scientific Misconduct
by: Ferric C. Fang, et al.
Published: (2013)

Bacteriophages as Pathogens and Immune Modulators?
by: A. Lengeling, et al.
Published: (2013)

Erratum for Schloss et al., “Support Science by Publishing in Scientific Society Journals”
by: Patrick D. Schloss, et al.
Published: (2017)

Are Men More Likely than Women To Commit Scientific Misconduct? Maybe, Maybe Not
by: Anna Kaatz, et al.
Published: (2013)

Ancient-Pathogen Genomics: Coming of Age?
by: Adrian M. Whatmore
Published: (2014)

The Presence of Female Conveners Correlates with a Higher Proportion of Female Speakers at Scientific Symposia
by: Arturo Casadevall, et al.
Published: (2014)

Interspecies Communication among Commensal and Pathogenic Streptococci
by: Laura C. Cook, et al.
Published: (2013)

Polymicrobial Interactions Operative during Pathogen Transmission
by: Hannah M. Rowe, et al.
Published: (2021)

Oxygen Limitation within a Bacterial Aggregate
by: Aimee K. Wessel, et al.
Published: (2014)

Bacteriophages Limit the Existence Conditions for Conjugative Plasmids
by: Ellie Harrison, et al.
Published: (2015)

Completion of an Experiment
by: Michael J. Imperiale, et al.
Published: (2018)